Circulating antibodies to cysteinyl catecholamines in amyotrophic lateral sclerosis and Parkinson's disease patients

Abstract

Amyotrophic lateral sclerosis (ALS) is a degenerative disease of unknown aetiology, affecting motor neurons. Many radical species, such as O₂⁻ NO, and ONOO⁻, and lipoperoxidative products are involved, but not all processes have yet been identified. It is known that the oxidation of catecholamines leads to quinone formation. These orthoquinones react with the sulphhydril group of cysteine to produce neurotoxic cysteinyl catecholamine (Cyst‐CA) neo‐compounds. We synthesised Cyst‐CA in order to mimic their endogenous formation. Using the ELISA method, circulating antibodies to Cyst‐CA were found in sporadic ALS sera. First, the antibody titres were compared to those of controls and patients with other neurodegenerative diseases. Significant antibody levels were found for Cyst‐CA. The G and A isotypes were found but not the M isotype. A second series of experiments showed that A and G titres were elevated, depending on the type of Cyst‐CA and the onset of the disease. IgG to Cyst‐3,4‐dihydroxyphenylalanine (L‐DOPA) were present in cases of bulbar and upper limb onsets. IgA to Cyst‐homovanillic acid (HVA), Cyst‐adrenaline (A), and Cyst‐dopamine (DA) were found in lower limb onset. These results indirectly show that: 1) the oxidation of CA and the formation of Cyst‐CA may be involved in ALS; 2) these radical processes have different targets depending on the onset of the disease.

• ALS
• circulating antibodies
• cysteinyl catecholamines
• radical species